Hisato Nako

700 total citations
16 papers, 606 citations indexed

About

Hisato Nako is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Hisato Nako has authored 16 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Physiology. Recurrent topics in Hisato Nako's work include Renin-Angiotensin System Studies (8 papers), Hormonal Regulation and Hypertension (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). Hisato Nako is often cited by papers focused on Renin-Angiotensin System Studies (8 papers), Hormonal Regulation and Hypertension (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). Hisato Nako collaborates with scholars based in Japan and United States. Hisato Nako's co-authors include Hisao Ogawa, Shokei Kim‐Mitsuyama, Taishi Nakamura, Keiichiro Kataoka, Yi‐Fei Dong, Yoshiko Tokutomi, Masaya Fukuda, Eiichiro Yamamoto, Nobutaka Koibuchi and Kensuke Toyama and has published in prestigious journals such as Circulation, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Hisato Nako

16 papers receiving 601 citations

Peers

Hisato Nako

CCM

EDM

PHYSI

SURGE

Masaya Fukuda Japan

Shinji Matsuba Japan

Kensaku Maeda Japan

Ana Sánchez Spain

Rhian M. Touyz Canada

Crisanto Escano United States

Maria Van den Enden Belgium

Motoyoshi Ikebuchi Japan

E. Cediel Spain

Isabel N. Schellinger Germany

Masaya Fukuda Japan

Hisato Nako

238 ×0.9

CCM

130 ×0.8

EDM

229 ×1.4

137 ×0.9

PHYSI

85 ×1.1

SURGE

Citations per year, relative to Hisato Nako Hisato Nako (= 1×) peers Masaya Fukuda

Countries citing papers authored by Hisato Nako

Since Specialization

Citations

This map shows the geographic impact of Hisato Nako's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisato Nako with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisato Nako more than expected).

Fields of papers citing papers by Hisato Nako

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisato Nako. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisato Nako. The network helps show where Hisato Nako may publish in the future.

Co-authorship network of co-authors of Hisato Nako

This figure shows the co-authorship network connecting the top 25 collaborators of Hisato Nako. A scholar is included among the top collaborators of Hisato Nako based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisato Nako. Hisato Nako is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Dong, Yi‐Fei, Keiichiro Kataoka, Yoshiko Tokutomi, et al.. (2011). Beneficial Effects of Combination of Valsartan and Amlodipine on Salt-Induced Brain Injury in Hypertensive Rats. Journal of Pharmacology and Experimental Therapeutics. 339(2). 358–366. 24 indexed citations

Nakamura, Taishi, Masaya Fukuda, Keiichiro Kataoka, et al.. (2011). Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats. Hypertension Research. 34(7). 817–824. 15 indexed citations

Tokutomi, Yoshiko, Keiichiro Kataoka, Eiichiro Yamamoto, et al.. (2011). Vascular responses to 8‐nitro‐cyclic GMP in non‐diabetic and diabetic mice. British Journal of Pharmacology. 162(8). 1884–1893. 7 indexed citations

Dong, Yi‐Fei, Keiichiro Kataoka, Yoshiko Tokutomi, et al.. (2011). Perindopril, a centrally active angiotensin‐converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease. The FASEB Journal. 25(9). 2911–2920. 117 indexed citations

Nako, Hisato, Keiichiro Kataoka, Nobutaka Koibuchi, et al.. (2011). Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF. Hypertension Research. 35(2). 194–200. 40 indexed citations

Nakamura, Taishi, Keiichiro Kataoka, Yoshiko Tokutomi, et al.. (2011). Novel mechanism of salt-induced glomerular injury. Journal of Hypertension. 29(8). 1528–1535. 9 indexed citations

Yamamoto, Eiichiro, Keiichiro Kataoka, Yi‐Fei Dong, et al.. (2010). Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats. Journal of Hypertension. 28(6). 1321–1329. 36 indexed citations

Fukuda, Masaya, Taishi Nakamura, Keiichiro Kataoka, et al.. (2010). Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice. Journal of Hypertension. 28(2). 340–352. 55 indexed citations

Yamamoto, Eiichiro, Taishi Nakamura, Keiichiro Kataoka, et al.. (2010). Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation. Biochemical and Biophysical Research Communications. 403(3-4). 258–263. 26 indexed citations

10.

Dong, Yi‐Fei, Lei Liu, Zhong-Fang Lai, et al.. (2010). Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice. Journal of Hypertension. 28(7). 1554–1565. 32 indexed citations

11.

Fukuda, Masaya, Taishi Nakamura, Keiichiro Kataoka, et al.. (2010). Ezetimibe Ameliorates Cardiovascular Complications and Hepatic Steatosis in Obese and Type 2 Diabetic db/db Mice. Journal of Pharmacology and Experimental Therapeutics. 335(1). 70–75. 39 indexed citations

12.

Dong, Yi, Kazunori Kataoka, Taishi Nakamura, et al.. (2009). Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes. Diabetologia. 53(1). 180–191. 68 indexed citations

13.

Nakamura, Yoshinori, Yoshihiro Yamada, Hideki Shimomura, et al.. (2009). The effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction. Journal of Cardiology. 54(3). 416–424. 19 indexed citations

14.

Yamamoto, Eiichiro, Keiichiro Kataoka, Yi‐Fei Dong, et al.. (2009). Aliskiren Enhances the Protective Effects of Valsartan Against Cardiovascular and Renal Injury in Endothelial Nitric Oxide Synthase–Deficient Mice. Hypertension. 54(3). 633–638. 55 indexed citations

15.

Nakamura, Taishi, Keiichiro Kataoka, Masaya Fukuda, et al.. (2009). Critical Role of Apoptosis Signal-Regulating Kinase 1 in Aldosterone/Salt-Induced Cardiac Inflammation and Fibrosis. Hypertension. 54(3). 544–551. 63 indexed citations

16.

Kataoka, Keiichiro, Taishi Nakamura, Masaya Fukuda, et al.. (2009). Abstract 5538: Apoptosis Signal-Regulating Kinase (ASK) 2 Deficient Mice Have Salt-Resistant Hypertension With Cardiac Hypertrophy. Circulation. 120(suppl_18). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact